RVAC Medicines

Private

SingaporeHealthcare & Life Scienceshttps://rvacmed.com

Last Round

Series B

Apr 26, 2022

Total Funding Raised

$140M

Company Overview

RVAC Medicines is a biotechnology company that develops an mRNA platform to build a diverse pipeline of innovative vaccines and therapeutics to address unmet medical needs.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

mRNA platformmRNA vaccinebiotechmRNA therapeuticsdrug discoverylipid nanoparticleLNPCDMOcontract manufacturingbiopharmamedical countermeasuresvaccine developmentclinical-stage biotechplatform biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RVAC Medicines Comparables

Compare RVAC Medicines with similar companies based on industry and business-model similarity.

RVAC Medicines comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Innorna	88%
Immorna Biotherapeutics	83%
Strand Therapeutics	79%

View all Comparables

RVAC Medicines Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Apr 26, 2022

View all Funding Rounds

RVAC Medicines Investors

Notable investors and investment history

RVAC Medicines investors
Investor	Rounds
CBC Group	Series B
EDBI	Series B
Pavilion Capital	Series B
GS Holdings	Series B

View all Investors

RVAC Medicines Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

RVAC Medicines Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RVAC Medicines's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore

Employee Range17

Year Founded2021

Last FundingApr 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?